Medical
| Mon 02 Feb 2026
Alexandria, Feb. 2 -- AbbVie has filed a patent application for 1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 Inhibitors. This invention was developed by Doherty George A, Bhat Vikram, Brady Patrick, Dai Yujia, Gong Jianchun, Judd Andrew S, Souers Andrew J and Yu Yiyun.
The patent application number ..